Symbiox Investment & Trading C

BSE: SYMBIOX · Other Financial Services · sector

₹1.55BSE close 2026-10-26

Key numbers

Market cap₹4 cr

Price₹1.55

52w high / low₹4 / ₹1

P/E31.0xSector median 15.7x

P/B0.1xSector median 1.6x

Book value₹11.3

Dividend yield–Sector median 1.27%

ROE0.5%Sector median 1.3%

ROCE0.7%Sector median 0.7%

OPM15.9%Sector median 6.2%

Debt / equity0.00xSector median 0.03x

EV/EBITDA-55.2xSector median 17.7x

Interest cover–

Current ratio320.60x

Sales growth 3y-26.1%Sector median +22.5%

Profit growth 3y-2.0%Sector median +28.4%

PEG–

Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 96 companies in Other Financial Services (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹16 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
Net loss in 1 of the last 6 quarters.
Other income was 0% of net profit in the last 12 months.
No dividend in the last 5 financial years.
Price ₹1.55 on 2026-10-26: -58.1% from the 52-week high, +14.0% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹5.74 · low ₹1.49

Quarterly results

₹ cr	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1	0	0	0	1	0
EBITDA	-0	0	0	0	0	0
OPM %	-32.8%	19.6%	34.8%	22.2%	2.4%	42.3%
Other income	0	0	0	0	0	0
Net profit	-0	0	0	0	0	0
EPS (₹)	0.10	0.02	0.02	0.00	0.00	0.03
Revenue YoY					-33.6%	-43.5%
Profit YoY					–	+14.3%

Standalone figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	1	4	4	3	2	1
EBITDA	-1	0	0	0	0	0
Net profit	0	0	0	0	0	0
EPS (₹)	0.04	0.05	0.07	0.06	0.05	0.05
Revenue growth		+279.0%	-2.0%	-29.2%	-42.0%	–
Profit growth		+14.3%	+31.2%	-9.5%	-21.1%	–
Dividend / share (₹)	–	–	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	-26.2%	–	–
Net profit	-2.0%	–	–
EPS	0.0%	–	–
Share price	–	-28.6% (2y)	-39.9%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	32	32
Borrowings	0	0
Cash & equivalents	14	16
Total assets	32	32
Fixed assets	0	0
Capital work in progress	0	–
Investments	0	0
Receivables	0	0
Inventory	1	1
Payables	0	0

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	4	3
Cash from investing	-3	-3
Cash from financing	0	0
Capex	0	0
Free cash flow	4	3

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	0.6%	0.5%
ROCE %	0.8%	0.6%
Debtor days	21	65
Inventory days	224	232
Payable days	26	0
Cash conversion cycle (days)	219	297
Working capital days	4,188	7,256

Peers in Other Financial Services

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
ARCFIN	₹37,47,491 cr	43.0x	37,875.8x	0.8%	–	–	+66.4%	–
CRISIL	₹34,926 cr	39.5x	10.7x	29.1%	–	29.8%	–	–
RRP	₹10,960 cr	1,406.3x	1,211.9x	-60.1%	-47.5%	105.2%	–	–
ARCIL	₹3,972 cr	–	–	–	–	–	–	–
KISSHT	₹3,472 cr	6.5x	2.6x	21.0%	–	29.9%	–	–
GYFTR	₹1,229 cr	–	–	–	–	–	–	–
PRIMESECU	₹929 cr	35.5x	4.4x	13.2%	–	–	+23.5%	0.54%
CENTRUM	₹860 cr	–	2.8x	-73.4%	–	–	+42.1%	–
REGENCY	₹565 cr	23.9x	3.0x	14.1%	–	–	+277.6%	–
SYMBIOX	₹4 cr	31.0x	0.1x	0.5%	0.7%	15.9%	-26.1%	–

All 96 companies in Other Financial Services →

Documents

Links go to the original files on the exchange website.

About the company


Sector	Financial Services
Industry	Other Financial Services
Sub-industry	Other Financial Services
Symbol	SYMBIOX
BSE code	539278
ISIN	INE653R01012
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.